Overview

  • Product name
  • Description
    Goat polyclonal to Fetuin
  • Tested applications
    Suitable for: ELISA, WBmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Recombinant fragment (alpha 2-HS glycoprotein) processed to remove a 40 amino acid residue bridging peptide resulting in the mature form of the protein (Human).

  • Positive control
    • WB: Human serum or purified Fetuin.

Properties

  • Form
    Liquid
  • Storage instructions
    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
  • Storage buffer
    Preservative: 0.01% Sodium Azide
    Constituents: 0.15M Sodium chloride, 0.02M Potassium phosphate. pH 7.2
  • Concentration information loading...
  • Purity
    IgG fraction
  • Purification notes
    Ab34505 was purified from monospecific antiserum by a multistep process which includes delipidation, salt fractionation and ion exchange chromatography followed by extensive dialysis against the buffer stated above.
  • Clonality
    Polyclonal
  • Isotype
    IgG
  • Research areas

Applications

Our Abpromise guarantee covers the use of ab34505 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
ELISA
WB
  • Application notes
    ELISA: 1/40,000 - 1/200,000.
    WB: 1/10000 - 1/20000. Detects a band of approximately 58 kDa.

    Although not tested, this antibody is likely functional in immunohistochemistry and immunoprecipitation.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • Function
      Promotes endocytosis, possesses opsonic properties and influences the mineral phase of bone. Shows affinity for calcium and barium ions.
    • Tissue specificity
      Synthesized in liver and selectively concentrated in bone matrix. Secreted in plasma. It is also found in dentin in much higher quantities than other plasma proteins.
    • Sequence similarities
      Belongs to the fetuin family.
      Contains 2 cystatin fetuin-A-type domains.
    • Post-translational
      modifications
      Phosphorylation sites are present in the extracelllular medium.
      O- and N-glycosylated. O-glycosylated with core 1 or possibly core 8 glycans. N-glycan at Asn-156: Hex5HexNAc4; N-glycan heterogeneity at Asn-176: Hex5HexNAc4 (major) and Hex6HexNAc5 (minor).
    • Cellular localization
      Secreted.
    • Information by UniProt
    • Database links
    • Alternative names
      • 16G2 antibody
      • A2HS antibody
      • AHS antibody
      • Ahsg antibody
      • Alpha 2 HS glycoprotein antibody
      • Alpha 2 Z globulin antibody
      • Alpha 2HS glycoprotein antibody
      • Alpha-2-HS-glycoprotein chain B antibody
      • Alpha-2-Z-globulin antibody
      • Ba alpha 2 glycoprotein antibody
      • Ba-alpha-2-glycoprotein antibody
      • FETUA antibody
      • FETUA_HUMAN antibody
      • FETUB antibody
      • Fetuin A antibody
      • Fetuin B antibody
      • Fetuin like protein antibody
      • Fetuin-A antibody
      • FetuinA antibody
      • FetuinB antibody
      • Gugu antibody
      • HSGA antibody
      • IRL 685 antibody
      • IRL685 antibody
      • PRO2743 antibody
      see all

    Anti-Fetuin antibody images

    References for Anti-Fetuin antibody (ab34505)

    This product has been referenced in:
    • Kutikhin AG  et al. Apoptosis-mediated endothelial toxicity but not direct calcification or functional changes in anti-calcification proteins defines pathogenic effects of calcium phosphate bions. Sci Rep 6:27255 (2016). WB . Read more (PubMed: 27251104) »

    See 1 Publication for this product

    Product Wall

    There are currently no Abreviews or Questions for ab34505.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

    Sign up